Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Colizzi

Showing results (91-100 of 112) with videos related to

Pageof 12
Sort By:
Irish Journal of Psychological Medicine|February 14, 2024
COVID-19-induced neuropsychiatric symptoms can persist long after acute infection: a 2-year prospective study of biobehavioral risk factors and psychometric outcomesMarco Colizzi, Carla Comacchio, Maria De Martino, et al.
BMC Psychiatry|December 5, 2024
Clinical heterogeneity of feeding and eating disorders: using personality psychopathology to differentiate "simplex" and "complex" phenotypesMarco Colizzi, Carla Comacchio, Marco Garzitto, et al.
Schizophrenia Research|April 15, 2018
Interaction between childhood adversity and functional polymorphisms in the dopamine pathway on first-episode psychosisAntonella Trotta, Conrad Iyegbe, Jenny Yiend, et al.
Frontiers in Psychiatry|November 6, 2024
Assessing the biobehavioral effects of ultramicronized-palmitoylethanolamide monotherapy in autistic adults with different severity levels: a report of two casesRiccardo Bortoletto, Fabiana Piscitelli, Marta Basaldella, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|June 5, 2016
Prefrontal activity during working memory is modulated by the interaction of variation in CB1 and COX2 coding genes and correlates with frequency of cannabis usePaolo Taurisano, Linda A Antonucci, Leonardo Fazio, et al.
Translational Psychiatry|April 23, 2020
Association of cannabis with glutamatergic levels in patients with early psychosis: Evidence for altered volume striatal glutamate relationships in patients with a history of cannabis use in early psychosisMusa Sami, Amanda Worker, Marco Colizzi, et al.
The Lancet. Psychiatry|August 28, 2016
Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational studyTabea Schoeler, Natalia Petros, Marta Di Forti, et al.
Psychological Medicine|November 6, 2018
Jumping to conclusions at first onset of psychosis predicts longer admissions, more compulsory admissions and police involvement over the next 4 years: the GAP studyVictoria Rodriguez, Olesya Ajnakina, Simona A Stilo, et al.
Schizophrenia Research|July 31, 2017
Hyperprolactinaemia in first episode psychosis - A longitudinal assessmentJohn Lally, Olesya Ajnakina, Brendon Stubbs, et al.
Schizophrenia Research|January 1, 2016
Substance use, medication adherence and outcome one year following a first episode of psychosisMarco Colizzi, Elena Carra, Sara Fraietta, et al.
Pageof 12

Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
Irish Journal of Psychological Medicine|February 14, 2024
COVID-19-induced neuropsychiatric symptoms can persist long after acute infection: a 2-year prospective study of biobehavioral risk factors and psychometric outcomesMarco Colizzi, Carla Comacchio, Maria De Martino, et al.
BMC Psychiatry|December 5, 2024
Clinical heterogeneity of feeding and eating disorders: using personality psychopathology to differentiate "simplex" and "complex" phenotypesMarco Colizzi, Carla Comacchio, Marco Garzitto, et al.
Schizophrenia Research|April 15, 2018
Interaction between childhood adversity and functional polymorphisms in the dopamine pathway on first-episode psychosisAntonella Trotta, Conrad Iyegbe, Jenny Yiend, et al.
Frontiers in Psychiatry|November 6, 2024
Assessing the biobehavioral effects of ultramicronized-palmitoylethanolamide monotherapy in autistic adults with different severity levels: a report of two casesRiccardo Bortoletto, Fabiana Piscitelli, Marta Basaldella, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|June 5, 2016
Prefrontal activity during working memory is modulated by the interaction of variation in CB1 and COX2 coding genes and correlates with frequency of cannabis usePaolo Taurisano, Linda A Antonucci, Leonardo Fazio, et al.
Translational Psychiatry|April 23, 2020
Association of cannabis with glutamatergic levels in patients with early psychosis: Evidence for altered volume striatal glutamate relationships in patients with a history of cannabis use in early psychosisMusa Sami, Amanda Worker, Marco Colizzi, et al.
The Lancet. Psychiatry|August 28, 2016
Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational studyTabea Schoeler, Natalia Petros, Marta Di Forti, et al.
Psychological Medicine|November 6, 2018
Jumping to conclusions at first onset of psychosis predicts longer admissions, more compulsory admissions and police involvement over the next 4 years: the GAP studyVictoria Rodriguez, Olesya Ajnakina, Simona A Stilo, et al.
Schizophrenia Research|July 31, 2017
Hyperprolactinaemia in first episode psychosis - A longitudinal assessmentJohn Lally, Olesya Ajnakina, Brendon Stubbs, et al.
Schizophrenia Research|January 1, 2016
Substance use, medication adherence and outcome one year following a first episode of psychosisMarco Colizzi, Elena Carra, Sara Fraietta, et al.
Pageof 12